Item no. |
HY-12694-50mg |
Manufacturer |
MedChem Express
|
CASRN |
179474-85-2 |
Amount |
50 mg |
Quantity options |
100 mg
10 mM/1 mL
10 mg
200 mg
50 mg
5 mg
|
Category |
|
Type |
Inhibitors |
Clone |
N/A |
Specific against |
other |
Purity |
99.95 |
Formula |
C22H32ClN3O7 |
Citations |
[1]Briejer MR, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol. 2001 Jun 29;423(1):71-83. [2]Johnson DE, et al. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations. J Pharmacol Exp Ther. 2012 Jun;341(3):681-91. [3]Wang Y, et al. Prucalopride might improve intestinal motility by promoting the regeneration of the enteric nervous system in diabetic rats. Int J Mol Med. 2022 Jul;50(1):87. [4]Chen M, et al. Prucalopride inhibits lung cancer cell proliferation, invasion, and migration through blocking of the PI3K/AKT/mTor signaling pathway. Hum Exp Toxicol. 2020 Feb;39(2):173-181. |
Smiles |
O=C(O)CCC(O)=O.O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC3CCN(CCCOC)CC3 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
R-108512 |
Shipping condition |
Room temperature |
Available |
|
Manufacturer - Type |
Reference compound |
Manufacturer - Targets |
5-HT Receptor; Apoptosis; Autophagy |
Shipping Temperature |
Room Temperature |
Storage Conditions |
4°C (Powder, sealed storage, away from moisture) |
Molecular Weight |
485.96 |
Product Description |
Prucalopride succinate is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride succinate improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride succinate also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride succinate can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer[1][2][3][4]. |
Manufacturer - Research Area |
Cancer; Metabolic Disease |
Solubility |
DMSO : 50 mg/mL (ultrasonic)|H2O : ≥ 20 mg/mL |
Manufacturer - Pathway |
Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling |
Isoform |
5-HT4 Receptor |
Clinical information |
Launched |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.